Search Within

Andrew D Seidman

Formats
  1. Journal Article (175)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
  4. Correspondence (3)
  5. Review (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Editorial (1)
Groups
  1. Breast Medicine Service (318)
  2. Department of Medicine (318)
  3. Solid Tumor Oncology Division (318)
  4. Survivorship Research (158)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (116)
  6. Epidemiology and Biostatistics (84)

More Groups

People
  1. Clifford Hudis (116)
  2. Larry Norton (99)
  3. Teresa Gilewski (38)
  4. Monica Fornier (37)
  5. Gabriella D'Andrea-Carlino (36)
  6. Violante Currie (32)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (9)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Breast Cancer Research and Treatment (25)
  3. Cancer Research (23)
  4. Clinical Breast Cancer (19)
  5. Seminars in Oncology (16)
  6. Oncology (Norwalk) (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. Elsevier Inc. (55)
  3. Springer (40)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (29)
  6. C M P Medica LLC * The Oncology Group (14)

More Publishers

Results (318)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Dose-dense therapy with paclitaxel via weekly 1-hour infusion: Preliminary experience in the treatment of metastatic breast cancer
    Conference Paper

    Seidman, A. D.; Hudis, C. A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M. E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L.
    Elsevier Inc. (1997)

    Fulltext@MSK | Save
  • Docetaxel and paclitaxel in breast cancer therapy: Present status and future prospects
    Journal Article

    D'Andrea, G. M.; Seidman, A. D.
    Seminars in Oncology (1997)

    Fulltext@MSK | Save
  • Paclitaxel for breast cancer: The Memorial Sloan-Kettering Cancer Center experience
    Conference Paper

    Seidman, A. D.; Hudis, C. A.; Raptis, G.; Baselga, J.; Fennelly, D.; Norton, L.
    C M P Medica LLC * The Oncology Group (1997)

    Fulltext@MSK | Save
  • HER2 overexpression and paclitaxel sensitivity in breast cancer: Therapeutic implications
    Conference Paper

    Baselga, J.; Seidman, A. D.; Rosen, P. P.; Norton, L.
    C M P Medica LLC * The Oncology Group (1997)

    Fulltext@MSK | Save
  • Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
    Journal Article

    Forsyth, P. A.; Balmaceda, C.; Peterson, K.; Seidman, A. D.; Brasher, P.; DeAngelis, L. M.
    Journal of Neuro-Oncology (1997)

    Fulltext@MSK | Save
  • Phase II study of semisynthetic paclitaxel in metastatic breast cancer
    Journal Article

    Hudis, C.; Riccio, L.; Holmes, F.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Moynahan, M.; Raptis, G.; more...
    European Journal of Cancer (1997)

    Fulltext@MSK | Save
  • Determination of urinary 6-beta-hydroxycortisol and cortisol ratio by capillary electrophoresis
    Meeting Abstract

    Lin, S.; Fleisher, M.; Seidman, A.; Spriggs, D.; Tong, W. P.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • A phase II and pharmacologic study of Taxol (T) by weekly one-hour (1-h) infusion in the treatment of patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    McCaffrey, J. A.; Seidman, A. D.; Tong, W.; Currie, V.; Hudis, C.; Gorman, C.; Moynahan, M.; Theodoulou, M.; Gollub, M.; Norton, L.
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save